Preference Among Users – Small Molecule Drug Substance

In Q32021, ISR asked API outsourcers which CDMOs they are currently working with, and if the choice were entirely up to them, which CDMO would they prefer to use for all small molecule drug substance manufacturing. The data show that Cambrex, Patheon, Lonza, STA Pharma and Pfizer CentreOne are each the preferred CDMO among roughly one-third of their current customers. To learn more about CDMO preference among users, follow the link to the Small Molecule API CDMO Benchmarking report preview.